GH Research PLC, together with its subsidiary, a clinical-stage biopharmaceutical company, engages in developing treatments for depression in the United States. Its lead product candidate is GH001, an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback